The antidepressant-like effect of Hedyosmum brasiliense and its sesquiterpene lactone, podoandin in mice: Evidence for the involvement of adrenergic, dopaminergic and serotonergic systems

European Journal of Pharmacology

Volumn 674, Issue 2-3, 2012, Pages 307-314

  Gonçalves, Ana Elisa ^a   Bürger, Cristiani ^a   Amoah, Solomon K S ^b   Tolardo, Rogério ^a   Biavatti, Maique W ^b   De Souza, Márcia M ^a  

^a UNIVERSIDADE DO VALE DO ITAJAÍ   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Antidepressant effect; Forced swimming test; Hedyosmum brasiliense; Hypnotic; Podoandin; Sesquiterpene lactone

Indexed keywords

1 (2 METHOXYPHENYL) 4 (4 PHTHALIMIDOBUTYL)PIPERAZINE; 7 CHLORO 8 HYDROXY 3 METHYL 1 PHENYL 2,3,4,5 TETRAHYDRO 1H 3 BENZAZEPINE HYDROCHLORIDE; 7 NITROINDAZOLE; ANTIDEPRESSANT AGENT; ARGININE; BENZAZEPINE DERIVATIVE; BICUCULLINE; FENCLONINE; HALOPERIDOL; HEDYOSMUM BRASILIENSE EXTRACT; KETANSERIN; METHYLENE BLUE; N(G) NITROARGININE; NALOXONE; NALTRINDOLE; ONDANSETRON; PHACLOFEN; PINDOLOL; PLANT EXTRACT; PODOANDIN; PRAZOSIN; SESQUITERPENE LACTONE DERIVATIVE; SULPIRIDE; UNCLASSIFIED DRUG; YOHIMBINE;

ANIMAL EXPERIMENT; ANTIDEPRESSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; FORCED SWIMMING TEST; HEDYOSMUM BRASILIENSE; IMMOBILIZATION; MALE; MOBILIZATION; MOUSE; NONHUMAN; NORADRENERGIC SYSTEM; OPEN FIELD TEST; PRIORITY JOURNAL; SEROTONINERGIC SYSTEM; SHRUB;

4-BUTYROLACTONE; ANALGESICS, OPIOID; ANIMALS; ANTIDEPRESSIVE AGENTS; ARGININE; CYCLIC GMP; CYCLOHEPTANES; DOPAMINE; DRUG INTERACTIONS; EPINEPHRINE; FERNS; FLUOXETINE; LACTONES; LOCOMOTION; MALE; MICE; NEUROTRANSMITTER AGENTS; NITRIC OXIDE; NOREPINEPHRINE; PLANT EXTRACTS; SEROTONIN; SESQUITERPENES; SWIMMING;

EID: 84855536488     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.11.009     Document Type: Article

References (56)

1. Berton, O., Nestler, E.J., 2006. New approaches to antidepressant drug discovery: beyond monoamines. Nat. Rev. Neurosci. 7, 137-151. (Pubitemid 43151600)
2. Blay, G., Bargues, V., Cardona, L., García, B., Pedro, J.R., 2000. Stereoselective synthesis of 7,11-guaien-8,12-olides fromsantonin. Synthesis of podoandin and (-)-zedolactone A. J. Org. Chem. 65, 6703-6707.
3. Boix, J., Llansola, M., Cabrera-Pastor, A., Felipo, V., 2011. Metabotropic glutamate receptor 5 modulates the nitric oxide-cGMP pathway in cerebellum in vivo through activation of AMPA receptors. Neurochem. Int. 58, 599-604.
4. Brocardo, P.S., Budni, J., Lobato, K.R., Kaster, M.P., Rodrigues, A.L., 2008. Antidepressant-like effect of folic acid: involvement of NMDA receptors and L-arginine-nitric oxide-cyclic guanosine monophosphate pathway. Eur. J. Pharmacol. 598, 37-42.
5. Brunello, N., Mendlewicz, J., Kasper, S., Leonard, B., Montgomery, S., Nelson, J., Paykel, E., Versiani, M., Racagni, G., 2002. The role of noradrenaline and selective noradrenaline reuptake inhibition in depression. Eur. Neuropsychopharmacol. 12, 461-475.
6. Bruno, M., Rosselli, S., Maggio, A., Raccuglia, R.A., Bastow, K.F., Lee, K.H., 2005. Cytotoxic activity of some natural and synthetic guaianolides. J. Nat. Prod. 68, 1042-1046. (Pubitemid 41151759)
7. Buller, R., Legrand, V., 2001. Novel treatments for anxiety and depression: hurdles in bringing them to the market. Drug Discov. Today 6, 1220-1230. (Pubitemid 33101895)
8. Capra, J.C., Cunha, M.P., Machado, D.G., Zomkowski, A.D., Mendes, B.G., Santos, A.R., Pizzolatti, M.G., Rodrigues, A.L., 2010. Antidepressant-like effect of scopoletin, a coumarin isolated from Polygala sabulosa (Polygalaceae) in mice: evidence for the involvement of monoaminergic systems. Eur. J. Pharmacol. 643, 232-238.
9. Castrén, E., 2005. Is mood chemistry? Nat. Rev. Neurosci. 6, 241-246. (Pubitemid 40342418)
10. Chung, I.M., Kim, E.H., Jeon, H.S., Moon, H.I., 2010. Protective effects of isoatriplicolide tiglate from Paulownia coreana against glutamate-induced neurotoxicity in primary cultured rat cortical cells. Nat. Prod. Commun. 5, 851-852.
11. Crespi, F., 2010. The selective serotonin reuptake inhibitor fluoxetine reduces striatal in vivo levels of voltammetric nitric oxide (NO): a feature of its antidepressant activity? Neurosci. Lett. 470, 95-99.
12. Da Silva, G.D., Matteussi, A.S., dos Santos, A.R., Calixto, J.B., Rodrigues, A.L.S., 2000. Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice. Neuroreport 11, 3699-3702.
13. Moret, C., Briley, M., 2011. The importance of norepinephrine in depression. Neuropsychiatr. Dis. Treat. 7, 9-13.
14. 1Areceptor antagonists. Psychopharmacology 119, 47-54.
15. Dhir, A., Kulkarni, S.K., 2007. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of venlafaxine in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 31, 921-925. (Pubitemid 46660304)
16. Dinas, P.C., Koutedakis, Y., Flouris, A.D., 2011. Effects of exercise and physical activity on depression. Ir. J. Med. Sci. 180, 319-325.
17. Eisensamer, B., Rammes, G., Gimpl, G., Shapa, M., Ferrari, U., Hapfelmeier, G., Bondy, B., Parsons, C., Gilling, K., Zieglgänsberger, W., Holsboer, F., Rupprecht, R., 2003. Antidepressants are functional antagonists at the serotonin type 3 (5-HT3) receptor. Mol. Psychiatry 12, 994-1007. (Pubitemid 37523911)
18. Ergün, Y., Ergün, U.G., 2007. Prevention of pro-depressant effect of L-arginine in the forced swim test by NG-nitro-L-arginine an [1H-[1, 2, 4]oxadiazole[4, 3-a]quinoxalin- 1-one]. Eur. J. Pharmacol. 554, 150-154. (Pubitemid 44879408)
19. Forster, E.A., Cliffe, I.A., Bill, D.J., Dover, G.M., Jones, D., Reilly, Y., Fletcher, A., 1995. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY 100635. Eur. J. Pharmacol. 281, 81-88.
20. Ghadirian, A.M., Gianoulakis, C.H., Nair, N.P., 1988. The effect of electroconvulsive therapy on endorphins in depression. Biol. Psychiatry 23, 459-464. (Pubitemid 18064894)
21. Ghose, S., Winter, M.K., McCarson, K.E., Tamminga, C.A., Enna, S.J., 2011. The GABAB receptor as a target for antidepressant drug action. Br. J. Pharmacol. 162, 1-17.
22. Gorwood, P., 2008. Neurobiological mechanisms of anhedonia. Dialogues Clin. Neurosci. 10, 291-299.
23. 3 receptor functions in the hippocampal CA1 region of rats following repeated electroconvulsive shock treatments. Neurosci. Lett. 307, 37-40.
24. Jesse, C.R., Wilhelm, E.A., Bortolatto, C.F., Rocha, J.B., Nogueira, C.W., 2010. Involvement of L-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of bis selenide in the mouse tail suspension test. Eur. J. Pharmacol. 635, 135-141.
25. Kaster, M.P., Raupp, I., Binfaré, R.W., Andreatini, R., Rodrigues, A.L.S., 2007. Antidepressant- like effect of lamotrigine in the mouse forced swimming test: evidence for the involvement of the noradrenergic system. Eur. J. Pharmacol. 565, 119-124. (Pubitemid 46795482)
26. Kirchner, K., Wisniewski Jr., A., Cruz, A.B., Biavatti, M.W., Netz, D.J.A., 2010. Chemical composition and antimicrobial activity of Hedyosmum brasiliense Miq., Chloranthaceae, essential oil. Rev. Bras. Farmacognosia 20, 692-699.
27. Krass, M., Wegener, G., Vasar, E., Volke, V., 2011. The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis. Behav. Brain Res. 218, 57-63.
28. Landau, A.M., Chakravarty, M.M., Clark, C.M., Zis, A.P., Doudet, D.J., 2011. Electroconvulsive therapy alters dopamine signaling in the striatum of non-human primates. Neuropsychopharmacology 36, 511-518.
29. Lin, T.Y., Yang, T.T., Lu, C.W., Wang, S.J., 2011. Inhibition of glutamate release by bupropion in rat cerebral cortex nerve terminals. Prog. Neuropsychopharmacol. Biol. Psychiatry 35, 598-606.
30. Maas, M., Hensel, A., Costa, F.B., Brun, R., Kaiser, M., Schmidt, T.J., 2011. An unusual dimeric guaianolide with antiprotozoal activity and further sesquiterpene lactones from Eupatorium perfoliatum. Phytochemistry 72, 635-644.
31. Machado, D.G., Kaster,M.P., Binfaré, R.W., Dias,M., Santos, A.R., Pizzolatti,M.G., Brighente, I.M., Rodrigues, A.L., 2007. Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system. Progr. Neuropsychopharmacol. 31, 421-428. (Pubitemid 46209437)
32. Mitchell, P.J., Redfern, P.H., 2005. Animal models of depressive illness: the importance of chronic drug treatment. Curr. Pharm. Des. 11, 171-203. (Pubitemid 40089840)
33. 1B receptors in the mediation of behavior in the forced swim test in mice. Neuropsychopharmacology 24, 391-398.
34. O'Sullivan, J.B., Ryan, K.M., Curtin, N.M., Harkin, A., Connor, T.J., 2009. Noradrenaline reuptake inhibitors limit neuroinflammation in rat cortex following a systemic inflammatory challenge: implications for depression and neurodegeneration. Int. J. Neuropsychopharmacol. 12, 687-699.
35. Porsolt, R.D., Le Pichon, M., Jalfre, M., 1977. Depression: a new animal model sensitive to antidepressant treatments. Nature 266, 730-732. (Pubitemid 8073804)
36. Prieto, E., Mico, J.Á., Meana, J.J., Majadas, S., 2010. Neurobiological bases of quetiapine antidepressant effect in the bipolar disorder. Actas Esp. Psiquiatr. 38, 22-32.
37. Redrobe, J.P., Bourin, M., Colombel, M.C., Baker, G.B., 1998. Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology 138, 1-8. (Pubitemid 28319041)
38. Reitz, R., 1965. Clorantáceas. Flora Ilustrada Catarinense, Itajaí.
39. Rosa, A.O., Kaster, M.P., Binfaré, R.W., Morales, S., Martín-Aparicio, E., Navarro-Rico, M.L., Martinez, A., Medina, M., García, A.G., López, M.G., Rodrigues, A.L., 2008. Anti-depressant- like effect of the novel thiadiazolidinone NP031115 in mice. Progr. Neuropsychopharmacol. Biol. Psychiatry 32, 1549-1556.
40. Schreiber, S., Bleich, A., Pick, C.G., 2002. Venlafaxine and mirtazapine: different mechanisms of antidepressant action, common opioid-mediated antinociceptive effects - a possible opioid involvement in severe depression? J. Mol. Neurosci. 18, 143-149. (Pubitemid 34256401)
41. Snyder, S.H., 1992. Biosensors. NO release for good measure. Nature 358, 623.
42. Souza, V.C., Lorenzi, H., 2005. Botânica sistemática: guia ilustrado para identificação das famílias de Angiospermas da flora brasileira, baseado em APG II. Instituto Plantarum, Nova Odessa, São Paulo.
43. Sun, L., Shah, F., Helal, M.A.,Wu, Y., Pedduri, Y., Chittiboyina, A.G., Gut, J., Rosenthal, P.J., Avery, M.A., 2010. Design, synthesis, and development of novel guaianolide -endoperoxides as potential antimalarial agents. J. Med. Chem. 53, 7864-7868.
44. Tolardo, R., Zetterman, L., Bittencourtt, D.R., Mora, T.C., de Oliveira, F.L., Biavatti, M.W., Amoah, S.K., Bürger, C., de Souza, M.M., 2010. Evaluation of behavioral and pharmacological effects of Hedyosmum brasiliense and isolated sesquiterpene lactones in rodents. J. Ethnopharmacol. 128, 63-70.
45. Trentin, A.P., Santos, A.R., Guedes, A., Pizzolatti, M.G., Yunes, R.A., Calixto, J.B., 1999. Antinociception caused by the extract of Hedyosmum brasiliense and its active principle, the sesquiterpene lactone 13-hydroxy-8,9-dehydroshizukanolide. Planta Med. 65, 517-521. (Pubitemid 29399952)
46. Ulak, G., Mutlu, O., Akar, F.Y., Komsuoǧlu, F.I., Tanyeri, P., Erden, B.F., 2008. Neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole augment the effects of anti-depressants acting via serotonergic system in the forced swimming test in rats. Pharmacol. Biochem. Behav. 90, 563-568.
47. Ulak, G., Mutlu, O., Tanyeri, P., Komsuoglu, F.I., Akar, F.Y., Erden, B.F., 2010. Involvement of serotonin receptor subtypes in the antidepressant-like effect of TRIM in the rat forced swimming test. Pharmacol. Biochem. Behav. 95, 308-314.
48. Uppal, A., Singh, A., Gahtori, P., Ghosh, S.K., Ahmad, M.Z., 2010. Antidepressants: current strategies and future opportunities. Curr. Pharm. Des. 16, 4243-4253.
49. 1)-receptor in the acute behavioral effects of antidepressants. J. Pharmacol. Sci. 115, 279-292.
50. Wang, R., Xu, Y., Wu, H.L., Li, Y.B., Li, Y.H., Guo, J.B., Li, X.J., 2008. The antidepressant effects of curcumin in the forced swimming test involve 5-HT1 and 5-HT2 receptors. Eur. J. Pharmacol. 578, 43-50. (Pubitemid 350179755)
51. Wesolowska, A., Nikiforuk, A., Michalska, K., Kisiel, W., Chojnacka-Wojcik, E., 2006. Analgesic and sedative activities of lactucin and some lactucin-like guaianolides in mice. J. Ethnopharmacol. 107, 254-258. (Pubitemid 44247432)
52. Yamada, J., Sugimoto, Y., Yamada, S., 2004. Involvement of dopamine receptors in the anti-immobility effects of dopamine re-uptake inhibitors in the forced swimming test. Eur. J. Pharmacol. 504, 207-211. (Pubitemid 39488216)
53. Yasuno, F., Suhara, T., Ichimiya, T., Takano, A., Ando, T., Okubo, Y., 2004. Decreased 5- HT1A receptor binding in amygdala of schizophrenia. Biol. Psychiatry 55, 439-444. (Pubitemid 38338529)
54. Zomkowski, A.D.E., Rosa, A.O., Lin, J., Santos, A.R., Calixto, J.B., Rodrigues, A.L.S., 2004. Evidence for serotonin receptor subtypes involvement in agmatine antidepressantlike effect in the mouse forced swimming test. Brain Res. 1023, 253-263.
55. WHO, 2011a. Depression. World Health Organization. [cited 2011 Apr 12] Available from http://www.who.int/mental-health/management/depression/ definition/en/.
56. WHO, 2011b. Traditional Medicine. World Health Organization. [cited 2011 Apr 12] Available from http://www.who.int/mediacentre/factsheets/fs134/en/.